相似文献
1
Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.
Blood Transfus. 2010 Jul;8(3):155-8. doi: 10.2450/2009.0097-09.
2
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.
BMC Cardiovasc Disord. 2019 Jul 26;19(1):177. doi: 10.1186/s12872-019-1157-5.
3
The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.
Ann Transl Med. 2016 May;4(10):189. doi: 10.21037/atm.2016.03.58.
4
[A new setting of opportunistic cardiovascular screening: from blood donation to preventive cardiology. Preliminary results of the Cardiorisk program].
G Ital Cardiol (Rome). 2010 Jul-Aug;11(7-8):578-83.
5
Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors.
Blood Transfus. 2007 Jul;5(3):153-7. doi: 10.2450/2007.0020-07.
6
[Italian cardiovascular mortality charts of the CUORE Project: are they comparable with the SCORE charts?].
G Ital Cardiol (Rome). 2010 Feb;11(2):148-53.
7
Ten years cardiovascular risk estimation according to Framingham score and non HDL-cholesterol in blood donors.
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):24-7. doi: 10.1016/j.dsx.2014.05.005. Epub 2014 Jun 16.
8
Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
Clin Cardiol. 2018 Jun;41(6):788-796. doi: 10.1002/clc.22955. Epub 2018 Jun 5.
9
Serum lipids and lipoproteins associations with ABO blood groups.
Anthropol Anz. 1994 Sep;52(3):221-30.
10
Discordance between non-HDL cholesterol and LDL cholesterol levels in patients with diabetes without previous cardiovascular events.
Diabetes Metab. 2010 Sep;36(4):299-304. doi: 10.1016/j.diabet.2010.02.002. Epub 2010 May 27.
引用本文的文献
1
Health promotion for blood donors: A scoping review.
Public Health Pract (Oxf). 2025 Mar 22;9:100604. doi: 10.1016/j.puhip.2025.100604. eCollection 2025 Jun.
2
Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients.
Healthcare (Basel). 2024 Jun 8;12(12):1165. doi: 10.3390/healthcare12121165.
3
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.
BMC Cardiovasc Disord. 2019 Jul 26;19(1):177. doi: 10.1186/s12872-019-1157-5.
4
The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.
Ann Transl Med. 2016 May;4(10):189. doi: 10.21037/atm.2016.03.58.
本文引用的文献
1
Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors.
Blood Transfus. 2007 Jul;5(3):153-7. doi: 10.2450/2007.0020-07.
2
Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):562-70. doi: 10.1097/01.hjr.0000221866.27039.4b.
3
Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples.
Am J Epidemiol. 2006 May 15;163(10):893-902. doi: 10.1093/aje/kwj110. Epub 2006 Mar 22.
4
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
Int J Epidemiol. 2005 Apr;34(2):413-21. doi: 10.1093/ije/dyh405. Epub 2005 Jan 19.
5
Reducing the risk of stroke.
JAMA. 2003 Apr 16;289(15):1928; author reply 1929. doi: 10.1001/jama.289.15.1928-a.
6
Evolution of NCEP guidelines: ATP1-ATPIII risk estimation for coronary heart disease in 2002. National Cholesterol Education Program.
Clin Cardiol. 2002 Mar;25(3):89-90. doi: 10.1002/clc.4960250302.
7
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
8
Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.
Eur Heart J. 2000 Mar;21(5):365-70. doi: 10.1053/euhj.1999.1864.
9
Lifetime risk of developing coronary heart disease.
Lancet. 1999 Jan 9;353(9147):89-92. doi: 10.1016/S0140-6736(98)10279-9.
10
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.
Circulation. 1998 May 12;97(18):1876-87. doi: 10.1161/01.cir.97.18.1876.
Zotero 插件